<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38191556</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>09</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Characteristics of long COVID and the impact of COVID-19 vaccination on long COVID 2 years following COVID-19 infection: prospective cohort study.</ArticleTitle><Pagination><StartPage>854</StartPage><MedlinePgn>854</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">854</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-023-50024-4</ELocationID><Abstract><AbstractText>This prospective cohort study aimed to identify characteristics of long COVID and any potential mitigating effects of COVID-19 vaccinations in patients 24&#xa0;months following COVID-19 infection. Adult patients diagnosed with COVID-19 between February 17, 2020, and March 24, 2020, were scheduled to visit the study hospital four times (6, 12, 18, and 24&#xa0;months after infection) to assess their symptoms, quality of life, and mental health. Among the 235 patients, 121 (51.5%) completed the study visits. Of these, 59.5% were female, with a median age of 52&#xa0;years. Mild to moderate disease severity were identified in 101 (83.4%)&#xa0;patients. A total of 75 participants (62.0%) were still experiencing long COVID symptoms 24&#xa0;months after acute infection. Fatigue, amnesia, difficulty concentrating, and insomnia were the most common symptoms. The frequency of neuropsychiatric symptoms did not differ based on vaccination status or the number of doses received. Quality of life improved over time for the participants, but 32.2% of respondents still reported anxiety/depression at the end of the study. Overall, our cohort demonstrates that long COVID can persist up to 24&#xa0;months after COVID-19 infection, affecting mental health and quality of life.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Yoonjung</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7454-4014</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130, Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sohyun</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3755-8249</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130, Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Hyun-Ha</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0002-9405-2121</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130, Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Shin-Woo</ForeName><Initials>SW</Initials><Identifier Source="ORCID">0000-0002-0206-7108</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, School of Medicine, Kyungpook National University Hospital, Kyungpook National University, 130, Dongdeok-ro, Jung-gu, Daegu, 41944, Republic of Korea. ksw2kms@knu.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>23</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38191556</ArticleId><ArticleId IdType="pmc">PMC10774352</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-50024-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-023-50024-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324:1723&#x2013;1724. doi: 10.1001/jama.2020.19719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, et al. Preliminary guidelines for the clinical evaluation and management of long COVID. Infect. Chemother. 2022;54:566&#x2013;597. doi: 10.3947/ic.2022.0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2022.0141</ArticleId><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, et al. ESCMID rapid guidelines for assessment and management of long COVID. Clin. Microbiol. Infect. 2022;28:955&#x2013;972. doi: 10.1016/j.cmi.2022.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkataramani V, Winkler F. Cognitive deficits in long Covid-19. N. Engl. J. Med. 2022;387:1813&#x2013;1815. doi: 10.1056/NEJMcibr2210069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2210069</ArticleId><ArticleId IdType="pubmed">36351274</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, et al. Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 2022;28:879&#x2013;882. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection. 2022;50:1053&#x2013;1066. doi: 10.1007/s15010-022-01835-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01835-6</ArticleId><ArticleId IdType="pmc">PMC9055372</ArticleId><ArticleId IdType="pubmed">35489015</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43:268&#x2013;270. doi: 10.1016/j.it.2022.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.008</ArticleId><ArticleId IdType="pmc">PMC8901423</ArticleId><ArticleId IdType="pubmed">35272932</ArticleId></ArticleIdList></Reference><Reference><Citation>Lempriere S. Inflammation links mild COVID-19 with long-term cognitive impairment. Nat. Rev. Neurol. 2022;18:453. doi: 10.1038/s41582-022-00694-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-022-00694-x</ArticleId><ArticleId IdType="pmc">PMC9244876</ArticleId><ArticleId IdType="pubmed">35773475</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e2416. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer A, et al. Long COVID symptomatology after 12 months and Its impact on quality of life according to initial coronavirus disease 2019 disease severity. Open Forum Infect. Dis. 2022;9:ofac397. doi: 10.1093/ofid/ofac397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac397</ArticleId><ArticleId IdType="pmc">PMC9379809</ArticleId><ArticleId IdType="pubmed">35983269</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;1714. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, et al. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549. doi: 10.1016/j.eclinm.2022.101549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona V, Kirouchena D, Clerc P, Pinsard-Laventure F, Bourrion B. Quality of life in COVID-19 outpatients: A long-term follow-up study. J. Clin. Med. 2022;11:6478. doi: 10.3390/jcm11216478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11216478</ArticleId><ArticleId IdType="pmc">PMC9657247</ArticleId><ArticleId IdType="pubmed">36362706</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson MM, et al. The epidemiology of long COVID in US adults. Clin. Infect. Dis. 2022 doi: 10.1093/cid/ciac961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac961</ArticleId><ArticleId IdType="pmc">PMC8800189</ArticleId><ArticleId IdType="pubmed">33949661</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyungerel B, Paulina S, Justin C, Kylie A, Paul G. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2:e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, et al. Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA. 2022;328:676&#x2013;678. doi: 10.1001/jama.2022.11691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, et al. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022;5:e2238804. doi: 10.1001/jamanetworkopen.2022.38804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Our wolrd in data. Coronavirus (COVID-19) vaccinations, &lt;https://ourworldindata.org/covid-vaccinations&gt; (2023).</Citation></Reference><Reference><Citation>ISARIC. COVID-19 long term protocol, global tier 1 initial follow up survey v1.2, &lt;https://isaric.org/research/covid-19-clinical-research-resources/covid-19-long-term-follow-up-study/&gt; (2021).</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/s1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandy Oemar BJ. EQ-5D-5L User Guide. &lt;https://www.unmc.edu/centric/_documents/EQ-5D-5L.pdf&gt;</Citation></Reference><Reference><Citation>Maroufizadeh S, Omani-Samani R, Almasi-Hashiani A, Amini P, Sepidarkish M. The reliability and validity of the Patient Health Questionnaire-9 (PHQ-9) and PHQ-2 in patients with infertility. Reprod. Health. 2019;16:137. doi: 10.1186/s12978-019-0802-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12978-019-0802-x</ArticleId><ArticleId IdType="pmc">PMC6734346</ArticleId><ArticleId IdType="pubmed">31500644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ, Kim YJ, Lee DH. South Korean validation of the COVID-related-PTSD scale in a non-clinical sample exposed to the COVID-19 pandemic. BMC Psychol. 2022;10:135. doi: 10.1186/s40359-022-00844-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40359-022-00844-2</ArticleId><ArticleId IdType="pmc">PMC9132603</ArticleId><ArticleId IdType="pubmed">35614519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, et al. Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea. BMC Infect. Dis. 2022;22:93. doi: 10.1186/s12879-022-07062-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07062-6</ArticleId><ArticleId IdType="pmc">PMC8793328</ArticleId><ArticleId IdType="pubmed">35086489</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, et al. Significance and associated factors of long-term sequelae in patients after acute COVID-19 infection in Korea. Infect. Chemother. 2021;53:463&#x2013;476. doi: 10.3947/ic.2021.0022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3947/ic.2021.0022</ArticleId><ArticleId IdType="pmc">PMC8511373</ArticleId><ArticleId IdType="pubmed">34405592</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, et al. One year follow-up of COVID-19 related symptoms and patient quality of life: a prospective cohort study. Yonsei Med. J. 2022;63:499&#x2013;510. doi: 10.3349/ymj.2022.63.6.499.</Citation><ArticleIdList><ArticleId IdType="doi">10.3349/ymj.2022.63.6.499</ArticleId><ArticleId IdType="pmc">PMC9171672</ArticleId><ArticleId IdType="pubmed">35619573</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung YH, et al. Persistent symptoms after acute COVID-19 infection in omicron era. J. Korean Med. Sci. 2022;37:e123. doi: 10.3346/jkms.2022.37.e213.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e213</ArticleId><ArticleId IdType="pmc">PMC9274102</ArticleId><ArticleId IdType="pubmed">35818704</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir. Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y-H, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study. JAMA Neurol. 2022;79:509&#x2013;517. doi: 10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyne JD, Brickman AM. The impact of the COVID-19 pandemic on dementia risk: Potential pathways to cognitive decline. Neurodegener. Dis. 2021;21:1&#x2013;23. doi: 10.1159/000518581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518581</ArticleId><ArticleId IdType="pmc">PMC8678181</ArticleId><ArticleId IdType="pubmed">34348321</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, et al. Development of a definition of postacute sequelae of SARS-CoV-2 infection. JAMA. 2023;329:1934&#x2013;1946. doi: 10.1001/jama.2023.8823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, et al. Prevalence and clinical features of long COVID from omicron infection in children and adults. J. Infect. 2023;86:e97&#x2013;e99. doi: 10.1016/j.jinf.2023.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.02.015</ArticleId><ArticleId IdType="pubmed">36803675</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Bae S, Chang HH, Kim SW. Long COVID prevalence and impact on quality of life 2 years after acute COVID-19. Sci. Rep. 2023;13:11207. doi: 10.1038/s41598-023-36995-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36995-4</ArticleId><ArticleId IdType="pmc">PMC10336045</ArticleId><ArticleId IdType="pubmed">37433819</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao X, et al. Long-term sequelae of different COVID-19 variants: The original strain versus the Omicron variant. Glob. Health Med. 2022;4:322&#x2013;326. doi: 10.35772/ghm.2022.01069.</Citation><ArticleIdList><ArticleId IdType="doi">10.35772/ghm.2022.01069</ArticleId><ArticleId IdType="pmc">PMC9773225</ArticleId><ArticleId IdType="pubmed">36589219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, et al. Post-COVID-19 symptoms 2 years after SARS-CoV-2 infection among hospitalized vs nonhospitalized patients. JAMA Netw Open. 2022;5:e2242106. doi: 10.1001/jamanetworkopen.2022.42106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.42106</ArticleId><ArticleId IdType="pmc">PMC9667330</ArticleId><ArticleId IdType="pubmed">36378309</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandmann FG, et al. Long-term health-related quality of life in non-hospitalized coronavirus disease 2019 (COVID-19) cases with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in England: Longitudinal analysis and cross-sectional comparison with controls. Clin. Infect. Dis. 2022;75:e962&#x2013;e973. doi: 10.1093/cid/ciac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac151</ArticleId><ArticleId IdType="pmc">PMC8903473</ArticleId><ArticleId IdType="pubmed">35245941</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh HS, Cho B. Long COVID-19 and health-related quality of life of mild cases in Korea: 3-months follow-up of a single community treatment center. J. Korean Med. Sci. 2022;37:e326. doi: 10.3346/jkms.2022.37.e326.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2022.37.e326</ArticleId><ArticleId IdType="pmc">PMC9705205</ArticleId><ArticleId IdType="pubmed">36631024</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey, D. et al. Change in symptoms and immune response in people with post-acute sequelae of SARS-Cov-2 infection (PASC) after SARS-Cov-2 vaccination. medRxiv, 2021.2007.2021.21260391 (2021). 10.1101/2021.07.21.21260391</Citation></Reference><Reference><Citation>Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>